The icelandic hypertrophic cardiomyopathy project: a recall-by-genotype study on MYBPC3 founder mutation carriers. echocardiographic data and b-type natriuretic peptide measurement.
Safety, tolerability, pharmacokinetics and pharmacodynamics of HRS-1893 in patients with obstructive hypertrophic cardiomyopathy: a randomized, double-blind, placebo-controlled phase 1 trial